# $capr

Capricor Therapeutics ($CAPR) sees a surge in social media buzz with mixed sentiment, driven by positive clinical trial news and FDA designations, but also facing scrutiny from short sellers.

### About $capr
Capricor Therapeutics is a biotechnology company focused on developing treatments for rare diseases, particularly Duchenne muscular dystrophy.  

### Engagements: [-----] (24h)
![Engagements Line Chart](https://lunarcrush.com/gi/w:600/t:$capr/c:line/m:interactions/iv:1d.svg)  
[Engagements 24-Hour Time-Series Raw Data](/topic/$capr/time-series/interactions.tsv)  
Current Value: [-----]  
Daily Average: [------]  
[--] Week: [------] +20,288%  
[--] Month: [-------] -68%  
[--] Months: [---------] +231%  
[--] Year: [----------] +180%  
1-Year High: [---------] on 2025-12-03  
1-Year Low: [---] on 2025-09-20  

Engagements by network (24h):
Reddit: [--]
YouTube: [--]
X: [-----]

  
  
### Mentions: [---] (24h)
![Mentions Line Chart](https://lunarcrush.com/gi/w:600/t:$capr/c:line/m:posts_active/iv:1d.svg)  
[Mentions 24-Hour Time-Series Raw Data](/topic/$capr/time-series/posts_active.tsv)  
Current Value: [---]  
Daily Average: [---]  
[--] Months: [---] +19,900%  
1-Year High: [-----] on 2025-12-04  
1-Year Low: [--] on 2025-04-12  

Mentions by network (24h):
Reddit: [--]
YouTube: [--]
X: [---]

  
  
### Creators: [---] (24h)
![Creators Line Chart](https://lunarcrush.com/gi/w:600/t:$capr/c:line/m:contributors_active/iv:1d.svg)  
[Creators 24-Hour Time-Series Raw Data](/topic/$capr/time-series/contributors_active.tsv)  
[---] unique social accounts have posts mentioning $capr in the last [--] hours which is up 103% from [--] in the previous [--] hours
Daily Average: [---]  
[--] Months: [---] +13,400%  
1-Year High: [-----] on 2025-12-04  
1-Year Low: [--] on 2025-10-24  

The most influential creators that mention $capr in the last [--] hours

| Creator                                              | Rank | Followers | Posts | Engagements |
| -------                                              | ---- | --------- | ----- | ----------- |
| [@bronxb_13](/creator/twitter/bronxb_13)             | [--]    | [--]        | [--]     | [-----]       |
| [@TradeLand_USA](/creator/twitter/TradeLand_USA)     | [--]    | [--]         | [--]     | [---]         |
| [@Tompson98315](/creator/twitter/Tompson98315)       | [--]    | [--]         | [--]     | [---]         |
| [@anthonystaj](/creator/twitter/anthonystaj)         | [--]    | [-----]     | [--]     | [---]         |
| [@Bigg0698830](/creator/twitter/Bigg0698830)         | [--]    | [--]        | [--]     | [---]         |
| [@gerbst78861](/creator/twitter/gerbst78861)         | [--]    | [--]         | [--]     | [---]         |
| [@mariostario2019](/creator/twitter/mariostario2019) | [--]    | [--]        | [--]     | [---]         |
| [@Botla129387](/creator/twitter/Botla129387)         | [--]    | [--]         | [--]     | [---]         |
| [@stockmktgenius](/creator/twitter/stockmktgenius)   | [--]    | [------]    | [--]     | [---]         |
| [@Jamce1182025](/creator/twitter/Jamce1182025)       | [--]   | [--]        | [--]     | [---]         |

[View More](/list/creators/$capr/100)
  
  
### Sentiment: 51%
![Sentiment Line Chart](https://lunarcrush.com/gi/w:600/t:$capr/c:line/m:sentiment/iv:1d.svg)  
[Sentiment 24-Hour Time-Series Raw Data](/topic/$capr/time-series/sentiment.tsv)  
Current Value: 51%  
Daily Average: 80%  
[--] Week: 50% -12%  
[--] Month: 46% -6%  
[--] Months: 46% -48%  
[--] Year: 46% -54%  
1-Year High: 100% on 2025-02-14  
1-Year Low: 17% on 2025-09-24  

Most Supportive Themes:
- Positive Clinical Trial Results: (60%) Capricor Therapeutics announced positive topline results from its Phase [--] HOPE-3 clinical study for Deramiocel, showing significant improvements in skeletal muscle and cardiac function for Duchenne patients.
- FDA Fast Track Designation: (20%) The FDA has granted a Fast Track designation for Deramiocel, indicating a potential for accelerated regulatory review and approval.
- Partnership with Nippon Shinyaku: (15%) The existing partnership with Nippon Shinyaku, which holds rights to Deramiocel in certain regions, is highlighted as a valuable asset.
  
Most Critical Themes:
- Short Seller Scrutiny and Short Squeeze: (70%) Prominent short sellers, including Martin Shkreli, have been vocal about their bearish stance on CAPR, with some facing significant losses due to a short squeeze.
- Market Volatility and Biotech Sector Risks: (20%) The biotech sector is inherently volatile, and concerns about overall market conditions and potential price corrections are present.
  

### Top $capr Social Posts
Top posts by engagements in the last [--] hours

*Showing a maximum of [--] top social posts without a LunarCrush subscription.*

"🎯 Momentum #Options Activity trade ideas Heavy institutional #optionsvolume far above daily average with strong consensus on direction. AM Algo #TradeIdea from 🔥 🔥 $TEVA $AEVA $HSBC $MVST $CAPR #OptionFlow #OptionsTrading #Trading http://INSIDERFINANCE.COM http://INSIDERFINANCE.COM"  
[X Link](https://x.com/InsiderFinancex/status/2022370903493857418) [@InsiderFinancex](/creator/x/InsiderFinancex) 2026-02-13T18:02Z 10.7K followers, [---] engagements


"Get daily investment strategies and trading tips directly in the group. 👉 Join 📈 $BYND $ASST $BITF $DTCK $CAPR $ZETA $NVDA $BE $NVDA $ONDS $PLUG $TSLA $AMZN $INTC $AAPL $MSFT $META $AMD $GOOGL $NFLX $PLTR $MU $BAC https://wa.me/12023901172 https://wa.me/12023901172"  
[X Link](https://x.com/Nkujob/status/2022370095587013019) [@Nkujob](/creator/x/Nkujob) 2026-02-13T17:59Z [---] followers, [---] engagements


"Get daily investment strategies and trading tips directly in the group. 👉 Join Reply STOCK for curated value/dividend stocks and precise buy/sell signals. 📈 $BYND $ASST $BITF $DTCK $CAPR $ZETA $NVDA $BE $NVDA $ONDS $PLUG $TSLA $AMZN $INTC $AAPL $MSFT $META $AMD $GOOGL $NFLX $PLTR $MU $BAC https://wa.me/12023901172 https://wa.me/12023901172"  
[X Link](https://x.com/RamMehar57/status/2022369714026996164) [@RamMehar57](/creator/x/RamMehar57) 2026-02-13T17:58Z [---] followers, [---] engagements


"Biotech Stock Catalyst Watchlist for Q1 [----] Probability of approval score card is below $ETON PDUFA $OCUL Phase [--] $TARA Phase [--] $REGN BLA $ASND PDUFA $XOMA Phase [--] $GOSS Phase [--] $CAPR BLA $RLAY Phase 1/2 $RYTM PDUFA $TELO Pre-clinical $RCKT PDUFA $LNTH PDUFA $ABVX Phase [--] $ALMS Phase [--] $MGX Preclinical $CTNM Phase 1b $SXTP Phase [--] $NAYA Phase 1/2a $ACAD Phase [--] https://twitter.com/i/web/status/2022341817685975187 https://twitter.com/i/web/status/2022341817685975187"  
[X Link](https://x.com/Biopharma_Watch/status/2022341817685975187) [@Biopharma_Watch](/creator/x/Biopharma_Watch) 2026-02-13T16:07Z [----] followers, [----] engagements

Limited data mode. Full metrics available with subscription: lunarcrush.com/pricing